On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
All content for Brains Behind AI is the property of Ari Yacobi and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
Comet: Gideon Mendels on Machine Learning Ops to track, compare, explain and optimize experiments and models
Brains Behind AI
34 minutes
4 years ago
Comet: Gideon Mendels on Machine Learning Ops to track, compare, explain and optimize experiments and models
On this Episode of “Brains Behind AI” Ari and Natalie had the opportunity to sit down with the CEO and co-founder of Comet.ml, Gideon Mendels. Comet.ml is a leading provider of machine learning operations solutions that accelerate getting machine learning models into production. Gideon has a wide range of expertise, previously founding GroupWize where he trained and deployed over 50 NLP models in 15 different languages. Comet.ml now supports some of the biggest and best machine learning teams...
Brains Behind AI
On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
